Clinical trial
Targeting Inflammation Using Salsalate in CardioVascular Disease (TINSAL-CVD)
NCT00624923 is registered in ClinicalTrials.gov with Joslin Diabetes Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeting Inflammation Using Salsalate in CardioVascular Disease (TINSAL-CVD)
- Lead sponsor
- Joslin Diabetes Center
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- September 30, 2008
- Completion date
- July 31, 2016
- Enrollment
- 340 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.